Markets
BSE See NSE See 49,206.47
256.71 (0.52%)

Alembic Pharma slips over 4 per cent despite getting USFDA nod for Ophthalmic solution

Shruti Dahiwal / Article rating: 5.0

Alembic Pharmaceuticals Limited, an Indian multinational pharmaceutical company, announced today that it has been granted final approval by US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic solution USP, 2 per cent and 0.5 per cent. 

First2345791011Last

Get A Call From Industry Experts

Send Otp

   I authorize DSIJ Pvt Ltd to contact me. This will override registry on the NDNC.

DSIJ MINDSHARE

12345Last

Knowledge

12345Last